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1. Introduction
   Propolis, bee pollen and royal jelly are bee products that 
have been ascribed several medical properties in both 
traditional medicine and more recently in conventional 
medicine[1]. Bee pollen is a granular composite of pollen 
collected by bees from various flowers and then compacted 
with a sticky substance produced by the bee. Propolis, often 
called bee glue, is produced by worker bees from collected 
plant resins or exudates from phloem-feeding insects, and 
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Objective: To screen crude extracts of propolis, bee pollen and honey from four stingless bee 
species [Trigona incisa (T. incisa)], Timia apicalis, Trigona fusco-balteata and Trigona fuscibasis) 
native to East Kalimantan, Indonesia for cytotoxic activity against five human cancer cell lines 
(HepG2, SW620, ChaGo-I, KATO-III and BT474). 
Methods: All samples were extracted with methanol, and then subpartitioned with n-hexane and 
ethyl acetate. Each crude extract was screened at 20 µg/mL for in vitro cytotoxicity against the cell 
lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. In addition, 
four previously shown bioactive components from propolis (apigenin, caffeic acid phenyl ester, 
kaempferol and naringenin) and two chemotherapeutic drugs (doxorubicin and 5-fluorouracil) 
were used to evaluate the sensitivity of the cell lines. 
Results: Overall, crude extracts from propolis and honey had higher cytotoxic activities than 
bee pollen, but the activity was dependent upon the extraction solvent, bee species and cell 
line. Propolis extracts from T. incisa and Timia apicalis showed the highest and lowest cytotoxic 
activity, respectively. Only the HepG2 cell line was broadly sensitive to the honey extracts. For 
pure compounds, doxorubicin was the most cytotoxic, the four propolis compounds the least, 
but the ChaGo-I cell line was sensitive to kaempferol at 10 µg/mL and KATO-III was sensitive to 
kaempferol and apigenin at 10 µg/mL. All pure compounds were effective against the BT474 cell 
line. 
Conclusions: Propolis from T. incisa and Trigona fusco-balteata contain an in vitro cytotoxic 
activity against human cancer cell lines. Further study is required, including the isolation and 
characterization of the active antiproliferative agent(s).
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is used to assemble, protect, or repair the bee hives[2]. Royal 
jelly is secreted by nurse bees and fed to all bee larvae 
during their first 3 days of development, but the continuous 
feeding to larvae at sufficient levels thereafter promotes the 
developmental switch to queen and not worker bees[3]. 
   In recent decades, propolis has attracted increasing 
attention and use in foods, beverages, supplements and 
cosmetics for both medicinal treatment and beneficial health 
reasons (preventative medicine). It is used to prevent or 
reduce some diseases or symptoms, such as inflammation, 
heart disease and cancer[4-6]. Propolis has been shown to 
have various biological activities, such as antibacterial, 
anti-inflammatory, antioxidant and anticancer properties, in 
support of its ancient use as a folk medicine in many regions 
of the world[7,8]. The chemical components of propolis depend 
on the resin from the vegetation within the foraging region of 
the bees and the plants the bees select for collection from, 
since honeybees preferentially target certain plants within 
range of their beehives as sources of propolis. Thus, propolis 
has been found to have a seasonal, geophysical regional and 
bee species specificity to its composition and bioactivity[9]. 
For example, Apis mellifera (A. mellifera) propolis collected 
in temperate regions contains many kinds of flavonoids and 
phenolic acid esters, particularly pinocembrin, pinobanksin, 
galangin, chrysin and caffeic acid phenyl ester (CAPE), as 
the main bioactive compounds[7,10]. The propolis from these 
regions was shown to have been collected from the bud 
exudates of members of the Populus genus[7,10]. However, 
the chemical composition of A. mellifera propolis has been 
found to be quite complicated with more than 300 identified 
compounds, such as polyphenols, phenolic aldehydes, 
sesquiterpene quinones, coumarins, amino acids, steroids 
and inorganic compounds, and to vary depending on the 
collecting location, time and plant source[4]. In contrast to A. 
mellifera propolis, the propolis from Tetragonula carbonaria, 
a stingless bee native to Australia, contained several isomers 
of pimaric acid and gallic acid as its main components[11,12]. 
Also, it was reported that eucalypt resin, especially that from 
Corymbia torelliana, shaped the chemical constituents in 
this stingless bee propolis[12]. 
   Besides A. mellifera propolis, Sawaya et al. reported 
the antioxidant activity of propolis from three stingless 
species[13], which were Scaptotrigona spp., Scaptotrigona 
depilis and Scaptotrigona bipunctata. Samples were collected 
monthly over a one-year period. Scaptotrigona spp. propolis 
was collected from the northeastern region of Brazil, while 
the rest was collected from the southeastern region of the 
country. Using the 1,1-diphenyl-2-picrylhydrazyl free 
radical scavenging method (DPPH), the composition of the 
samples and the antioxidant activity was assayed and found 
to vary according to the bee species, geographic region and 
month of collection. 
   Recently, nine species of stingless bees were recorded in 
the Mulawarman University Botanical Garden, Samarinda, 
Indonesia [Trigona apicalis (T. apicalis), Trigona drescheri, 
Trigona fuscibasis (T. fuscibasis), Trigona fuscobalteata 
(T. fuscobalteata), Trigona incisa (T. incisa), Trigona 
itama, Trigona laeviceps, Trigona melina and Trigona 
terminate][14]. Thirty nine plant species from 13 families 
were reported to act as their pollen source, whilst 22 plant 
species from 17 families belonging to forest plants and crops 
were reported to act as their nectar source[14]. The products 
of those stingless bees were honey (15.4%), beebread (20.9%) 
and propolis (63.7%).
   The existence of stingless bees in the Mulawarman 
University Botanical Garden is likely to be important in 
terms of the economics and ecology of the region, since 
these bees are essential in pollination and can also make 
useful bee products that can be harvested and applied in 
food products. However, no research on the bioactivities 
of products from stingless bees in this region has been 
reported, yet it is likely to be of interest given that the 
biological activities of propolis can vary greatly across 
different phytogeographical areas, time periods[4], and 
within the same region. Moreover, the bioactivity of bee 
products from different races or species of bees can also 
be different. For example, the propolis of Apis mellifera 
caucasica, Apis mellifera anatolica and Apis mellifera 
carnica collected from the same apiary in East Anatolia 
contained different chemical compositions and had different 
antimicrobial activities[15]. Hence, in this research, the in 
vitro cytotoxic activity of the propolis, bee pollen and honey 
from four stingless bees collected from within the same 
area (Mulawarman University Botanical Garden, Samarinda, 
Indonesia) was evaluated. Crude methanol, n-hexane and 
ethyl acetate extracts of those bee products were prepared 
and tested for their in vitro cytotoxic activity against five 
human cancer cell lines. In addition, the sensitivity of 
these five cell lines to four pure compounds (apigenin, 
CAPE, kaempferol and naringenin) previously reported to 
be some of the main bioactive components in A. mellifera 
propolis were evaluated in comparison with doxorubicin and 
5-fluorouracil (5-FU), two standard chemotherapeutic drugs. 
2. Materials and methods
2.1. Sample collection
   Propolis, bee pollen and honey were each harvested 
from four stingless bee species [T. incisa, T. apicalis, T. 
fuscobalteata and Trigona fuscibisca (T. fuscibisca)] collected 
in Mulawarman University Botanical Garden, Samarinda, 
East Kalimantan, Indonesia in February, 2013. All samples 
were kept at -20 °C until used. 
2.2. Sample preparation
   Propolis was cut into small pieces and ground. Bee pollen 
was collected by sifting with a sieve. Honey was filtered 
to remove the residual comb and solid matter, such as bee 
remains, and then by a sifter with the honey liquid being 
used directly. The samples (Table 1 for amounts) were then 
separately extracted in three times the volume of 96% (v/v) 
methanol at room temperature (RT) with continuous shaking 
(740 0 Tübingen; Edmun Buchler, Germany) at 100 r/min for 
24 h. This process was repeated until the color of extract was 
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almost clear (maximum of 7 d) and the extracts were pooled.
Table 1
Yields of the crude extracts of bee products.
Source
Methanol 
extractiona
IME extractionb
Initial 
(g)
IME yield 
(g) (%)
Initial 
(g)
CHE yield 
(g) (%)
CEE yield 
(g) (%)
CME 
yield (g) 
(%)
Propolis
T. incisa 50 45.8 (91.6) 5.0  0.2 (4.8) 2.5 (50.8) 1.9 (37.2)
T. apicalis 46 39.2 (85.2) 2.0 0.3 (16.0) 1.1 (53.0) 0.6 (30.5)
T. fuscibisca 50 46.3 (92.5) 5.0 0.5 (10.0) 3.6 (72.0) 0.9 (18.0)
T. fuscobalteata 50 43.7 (87.2)   10.0   0.7 (6.9) 6.9 (68.5) 1.8 (17.5)
Bee 
pollen
T. incisa 20  8.1 (40.7) 1.0 0.1 (10.0) 0.2 (20.0) 0.2 (22.0)
T. apicalis 27  7.3 (27.2) 3.7   0.1 (3.2)   0.2 (5.1) 2.3 (62.4)
T. fuscibisca 25  8.2 (33.0) 2.7   0.2 (7.0)   0.2 (7.8) 1.8 (65.2)
T. fuscobalteata 25  7.6 (30.6) 3.5   0.1 (2.9)   0.1 (2.9) 1.5 (42.9)
Honey
T. incisa 150 54.8 (36.5)   28.0   0.3 (1.1) 8.4 (30.0) 2.9 (10.4)
T. apicalis 150 48.6 (32.4)   28.0   0.2 (0.7) 3.3 (11.8) 3.7 (13.2)
T. fuscibisca 150 58.2 (38.8)   28.0   0.3 (1.1) 3.3 (11.8)   2.4 (8.6)
T. fuscobalteata 150 59.2 (39.4)   28.0   0.3 (1.1) 3.9 (13.9) 3.8 (13.6)
a: The initial amount of sample extracted by methanol, and the yield of the 
obtained initial methanol extract (IME). b: The amount of IME extracted with 
hexane/methanol and subsequent extraction of the methanol portion with 
ethyl acetate, with the yields obtained of the crude hexane extract (CHE), 
crude ethyl acetate extract (CEE) and crude methanol extract (CME).
   The respective pooled methanol (MeOH) extracts were 
then filtered through Whatman filter paper No. 2 (Sigma-
Aldrich, Germany) and the filtrate was evaporated at 40 
°C and dried in a vacuum oven to near dryness to yield 
the initial methanol extract (IME) (Table 1). A portion (see 
Table 1 for amounts) of each filtrate was then dissolved in 
the minimal volume of 60% (v/v) aqueous MeOH required 
for complete solvation, and then extracted (partitioned) at 
RT with an equal volume of n-hexane and left to phase 
separate. The two phases were harvested separately and 
the upper n-hexane phase was solvent evaporated as above 
to leave the crude hexane extract (CHE). The lower MeOH 
phase was further partitioned at RT with an equal volume 
of ethyl acetate (EtOAc) and then left to phase separate 
and harvested. The upper (EtOAc) phase was evaporated 
to the yield crude EtOAc extract (CEE), whilst on solvent 
evaporation the lower phase yielded the crude MeOH extract 
(CME) (Table 1). Each crude extract was then wrapped with 
aluminum foil and kept at RT until used. The fractionation 
yields obtained are summarized in Table 1. 
2.3. Cell culture 
   The human cancer derived cell lines used in this study 
were derived from ductal carcinoma (BT474, ATCC No. HTB 
20), lung undifferentiated cancer (ChaGo I, National Cancer 
Institute), liver hepatoblastoma (HepG2, ATCC No. HB8065), 
gastric carcinoma (KATO-III, ATCC No. HTB 103) and colon 
adenocarcinoma (SW620, ATCC No. CCL 227). All cell lines 
were obtained from the Institute of Biotechnology and 
Genetic Engineering, Chulalongkorn University, and were 
used at passage number 115 for BT474, 286 for ChaGo I, 57 
for HepG2, 134 for KATO-III and 160 for SW620. Cell lines 
were cultured in complete medium (CM; RPMI 1640 medium 
containing 5% (v/v) fetal calf serum) at 37 °C with 5% (v/v) 
CO2, seeding at 1伊10
5 cells/25-cm2 flask in 5 mL CM, and 
repassaging when at 70%-80% confluency.
2.4. Cell counts
   Adherent cells were harvested by removing the CM, 
washing with 0.01 mol/L phosphate buffer saline (PBS (pH 
7.4) with 0.01% EDTA but without Ca
2+ and Mg2+) and then 
incubating with 1-1.5 mL of 0.05% (w/v) trypsin in the 
same PBS at RT for 1-2 min. The trypsin solution was then 
replaced with CM (1.5-2 mL) and the cells dissociated by 
gentle agitation, harvested and the cell suspension further 
diluted as required such that a 10 µL aliquot could be 
counted using a hematocytometer. 
2.5. Determination of the extract cytotoxicity by the 
surrogate MTT assay
   The potential cytotoxicity (anti-proliferative and/or 
reduced cell viability) of each crude extract was assayed 
using the surrogate cell viability 3-(4,5-dimethyl-thiazol-
2-yl)2,5-diphenyl-tetrazolium bromide (MTT) assay, as 
previously reported[16]. In brief, cultured cells (5 000 cells) 
in 200 µL of CM were transferred into each well of a flat 96 
well plate and then incubated at 37 °C in a humidified air 
atmosphere enriched with 5% (v/v) CO2 for 24 h in order to 
let the cells attach to the bottom of each well. The cultured 
cells were then treated with the test extract (triplicate wells 
per condition) at a final concentration of 1, 0.1, 0.01, 0.001 
and 0 (solvent control) µg/mL by the addition of 2 µL of CM 
serial dilutions of the respective crude extract dissolved in 
dimethyl sulfoxide (stock concentration of 20 µg/mL). The 
cells were then cultured as above for another 48 h prior to 
the addition of 10 µL of a 5 mg/mL of MTT solution into each 
well. The incubation was continued for another 4 h before 
the media was removed. A mixture of dimethyl sulfoxide 
(150 µL) and 0.1 mol/L glycine (25 µL) was then added to 
each well and mixed to lyse the cells and dissolve the 
formazan crystals, prior to measuring the absorbance at 540 
nm. Three replications of each experiment were performed. 
The number of viable cells was then assumed from the ratio 
of the absorbance at 540 nm of the respective test sample to 
that of the control, taking the control to be 100% viability. 
Thus, the assay approximates the sum of any differential 
proliferation and cell viability, and so is referred to as the 
cytotoxicity without discrimination of the two activities. 
2.6. Data analysis
   Data are presented as the mean依SD, which derived 
from the indicated number of independent repeats. The 
significance of any difference between means was tested 
using a one-way analysis of variance (ANOVA) and Duncan’s 
multiple range tests (DMRT) when parametric, or a One-
way Kruskal-Wallis analysis of variance and Mann-
Whitney U test with Holm correction when non-parametric. 
Significance was accepted at the P<0.05 level.
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3. Results
3.1. Cytotoxic activity of the crude extracts against five human 
cancer cell lines
   Each crude extract was screened for potential in vitro 
cytotoxic activity against the five human cancer derived 
cell lines at a single concentration of 20 µg/mL. Those crude 
extracts that had a relative MTT level (assumed viable cell 
number) of less than 50% of that of the control were deemed 
to have a sufficient cytotoxic activity, whilst those with a 
greater than 130% relative viable cell number were deemed to 
be stimulatory. Note, however, this single high dose assumes 
no hormesis, where compounds at low concentrations are 
cytotoxic but not at higher concentrations, such as the 
potentially high concentration of 20 µg/mL used here.
   The obtained cytotoxic activities (and stimulatory activities) 
varied not only with the solvent used in the extraction, bee 
product source and bee species, as expected, but were also 
was markedly variant between the five different cell lines 
(Tables 2-4). 
   With respect to the bee product source, overall, the bee 
pollen was the least effective source with only two [crude 
n-hexane extract of bee pollen (CHEB) and crude EtOAc 
extract of bee pollen (CEEB)] of the three extracts from two 
(T. fuscobalteata and T. fuscobisca) of the four bee species 
showing a less than 50% relative viable cell number after a 
48 h exposure to the extracts, each on a different two of the 
five cell lines (Table 3). However, these four cases were fairly 
strongly cytotoxic with only a 8% relative viable cell number 
for SW620 with the CHEB extract from T. fuscobalteata, and the 
other three cases having a 20%-29% viable cell number. In 
contrast, the honey extracts showed the highest stimulatory 
activity, where six and four of the extracts resulted in a more 
than 130% viable cell number in the ChaGo-I and SW620 cell 
lines, respectively. Overall, the most cytotoxically active 
source was the propolis with all cell lines, bee species and 
solvent extracts showing a less than 50% viable cell number 
in at least some cases, although only the SW620 cell line had 
a reduced viable cell level to below 10% in three cases (Table 
2). Note, however, an increased relative viable cell number 
to over 130% was seen for three cell lines/bee species, with 
the HepG2 line being the most sensitive to this positive 
stimulation. For the honey extracts, the HepG2 line was the 
most cytotoxically sensitive (but note it also had two cases of 
enhanced viable cell number), followed by the ChaGo-I cell 
line but with no cases of the viable cell number falling below 
10%. The SW620 and KATO-III cell lines were insensitive to 
any honey extract tested (Table 4).
   With respect to the bee species, a significant variation 
in the cytotoxic activity was observed for the bee product, 
extraction solvent and tested cell line between the different 
bee species. Overall, the products from T. fuscobalteata and 
then T. fuscibasis were more cytotoxic than those from T. 
Table 2
Relative viable cell number (% of control) of five cancer cell lines after 48 h in vitro treatment with crude extracts of propolis from four stingless bee species.
Bee species Extract
Cell lines
HepG2 SW620 ChaGo-I KATO-III BT474
T. incisa
CMEP    59.000依0.042a      8.000依0.008A     33.000依0.083aa      18.000依0.001AA    33.000依0.020*
CHEP    74.000依0.062b   69.000依0.248     35.000依0.041bb   50.000依0.017     22.000依0.031**
CEEP 108.000依0.160      6.000依0.003B     15.000依0.011cc      17.000依0.001BB   83.000依0.004
T. apicalis
CMEP 125.000依0.076   78.000依0.010   85.000依0.054   53.000依0.015   73.000依0.024
CHEP 129.000依0.090   46.000依0.021   38.000依0.220   43.000依0.011   84.000依0.004
CEEP   90.000依0.064 125.000依0.164 170.000依0.099   95.000依0.004   96.000依0.027
T. fuscobalteata
CMEP   49.000依0.049c   15.000依0.016     16.000依0.006dd      20.000依0.008CC       38.000依0.069***
CHEP              119.000依0.043  133.000依0.058   93.000依0.005   76.000依0.029   65.000依0.053
CEEP   39.000依0.016d     7.000依0.018      18.000依0.024ee      18.000依0.003DD        29.000依0.044****
T. fuscibasis
CMEP              146.000依0.044     18.000依0.101C    26.000依0.018   45.000依0.040   55.000依0.010
CHEP  43.000依0.058  124.000依0.282    96.000依0.142   57.000依0.011   19.000依0.048
CEEP              114.000依0.050     50.000依0.086D    86.000依0.286   40.000依0.016   89.000依0.072
Data are shown as the mean依SD, derived from three repeats. Means within a column followed by a different letter are significantly different. CMEP: crude MeOH 
extract of propolis. CHEP: crude n-hexane extract of propolis. CEEP: crude EtOAc extract of propolis.
Table 3
Relative viable cell number (% of control) of five cancer cell lines after 48 h in vitro treatment with crude extracts of pollen from four stingless bee species.
Bee species Extract
Cell lines
HepG2 SW620 ChaGo-I KATO-III BT474
T. incisa CMEB 104.000依0.113 135.000依0.088 182.000依0.131 107.000依0.030 110.000依0.022
CHEB 127.000依0.139 114.000依0.121 139.000依0.101   95.000依0.006   95.000依0.053
CEEB 105.000依0.034   75.000依0.192   62.000依0.218   88.000依0.006   63.000依0.017
T. apicalis CMEB 129.000依0.056 154.000依0.082 180.000依0.077   99.000依0.039 113.000依0.067
CHEB 171.000依0.246 118.000依0.155 159.000依0.116 103.000依0.056 111.000依0.023
CEEB 104.000依0.019 125.000依0.038   78.000依0.147 117.000依0.039   55.000依0.021
T. fuscobalteata CMEB 119.000依0.213 152.000依0.143 159.000依0.046 108.000依0.014 114.000依0.036
CHEB   80.000依0.025    8.000依0.022    20.000依0.026aa 115.000依0.018   78.000依0.064
CEEB   95.000依0.036   94.000依0.115    57.000依0.014bb   93.000依0.012   76.000依0.011
T. fuscibasis CMEB   79.000依0.085 135.000依0.101 152.000依0.075 106.000依0.009 113.000依0.010
CHEB 116.000依0.053   76.000依0.034  84.000依0.075 106.000依0.050   76.000依0.067
CEEB   22.000依0.080 104.000依0.148  67.000依0.078 106.000依0.036   29.000依0.039
Data are shown as the mean依SD, derived from three repeats. Means within a column followed by a different letter are significantly different. CMEB: crude MeOH 
extract of bee pollen. CHEB: crude n-hexane extract of bee pollen. CEEB: crude EtOAc extract of bee pollen.
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incisa, with T. apicalis being the least cytotoxic source of 
bee products.
   The solvent used to extract the bee source was also very 
variable in the cytotoxicity results with no clear trend 
between the level of cytotoxicity and the bee species or the 
cell line, but in general the overall weak trend was that the 
methanol extract yielded a slightly more cytotoxic extract, 
except perhaps for the hexane extract of products from T. 
apicalis. It should be noted, however, that the different CHEs 
represent the hexane subfractionation of an initial aqueous 
methanol extraction, and not a direct hexane extraction 
of the bee products including propolis. Thus, non-polar 
and weakly polar bioactive compounds present in the bee 
products that would be extracted in hexane (but not in the 
aqueous methanol) may be absent or at lower concentrations 
in these CHEs.
   With respect to the cell lines used to measure the cytotoxic 
activity, overall the KATO-III cell line appeared the least 
sensitive of the five cell lines, with no cytotoxicity to below 
a 50% relative viable cell number in any bee pollen or honey 
extract, although it was probably the most sensitive cell line 
overall to the different propolis extracts. In addition, the 
SW620 cell line showed no significant level of cytotoxicity 
to any honey extract. The HepG2 cell line appeared the most 
sensitive to cytotoxic activity in the honey extracts (the 
least cytotoxic bee product), yet was the least sensitive to 
cytotoxic activity in the propolis extracts (the most cytotoxic 
bee product), whilst the reverse trend was seen for the KATO-
III cell line. 
3.2. Cytotoxic activity of known pure compounds on each of 
the five human cancer cell lines
   The dramatic variation in the apparent cytotoxicity of 
each crude extract of the bee products between the five 
different cell lines (Section 3.1) could question the relative 
sensitivity of these cell lines to different components of 
bee products and, therefore, the use of any one alone is in 
assays for screening for bioactive compounds. However, 
these were only crude extracts at one dose and so the 
results are potentially compounded by complex interactions 
between different components (synergistic or additive 
agonistic or antagonistic activities) within each crude 
extract. Accordingly, each of the same five cell lines were 
screened for the in vitro cytotoxicity of six known cytotoxic 
compounds as pure reagents. Of the six chosen compounds, 
apigenin, CAPE, kaempferol and naringenin have previously 
been reported to be the major bioactive compounds found 
in A. mellifera propolis[17-19], whilst 5-FU and doxorubicin 
are currently used chemotherapeutic drugs[20,21]. Each pure 
compound was tested over the range of 0.001-10 µg/mL (final 
concentration) for their in vitro cytotoxic activity against 
the five cancer cell lines in the same manner as the crude 
extracts of bee products using the MTT surrogate total viable 
cell number assay (Section 2.5). 
   As with the crude extracts of the bee products, the 
different cell lines showed different sensitivities to each of 
the six tested pure compounds (Figure 1). Although these 
appeared to be less marked between the different cell lines 
than that observed with the crude extracts of bee products, 
a direct comparison is not possible for various reasons, 
including that the concentrations used were quite different. 
   Doxorubicin was the most cytotoxic of all six tested 
compounds, with strong (<20% viable cell number) cytotoxic 
activity against the HepG2, SW620 and ChaGo-I cell lines, 
although the dose-responses clearly differed between these 
three cell lines, and moderate cytotoxic (<50% viable cell 
number) activity against the KATO-III and BT-474 cell lines 
(again with different dose responses). The sensitivity to 5-FU 
across the cell lines was less marked, with strong sensitivity 
only seen in the ChaGo-I cell line, moderate sensitivity 
in the SW620 and HepG2 lines, but only at high doses and 
with different dose responses, and a weak sensitivity in the 
KATO-III and BT474 lines. However, no significant increase in 
the viable cell number was noted with doxorubicin or 5-FU.
   With respect to the four pure compounds known to be 
bioactive (including cytotoxic activity) ingredients in 
propolis, none showed any strong cytotoxic activity to any 
of the cell lines, with a moderate cytotoxic activity (30%-
50% viable cell number) being observed only at the highest 
tested dose (10 µg/mL), but with variation between each cell 
line and each compound. In addition, at low concentrations 
(0.01 and 0.10 µg/mL) all four compounds appeared to be 
stimulatory (120%-140% viable cell number) and so may 
promote cell proliferation in the HepG2 cell line and, to a 
lesser extent, in the KATO-III cell line, but not in the other 
Table 4
Relative viable cell number (% of control) of five cancer cell lines after 48 h in vitro treatment with crude extracts of honey from four stingless bee species.
Bee species Extract Cell lines
HepG2 SW620 ChaGo-I KATO-III BT474
T. incisa CMEH   14.000依0.123a   71.000依0.047   30.000依0.190   65.000依0.005   38.000依0.034 
CHEH   18.000依0.053b   62.000依0.531   70.000依0.205 119.000依0.060 100.000依0.025 
CEEH   26.000依0.064c 109.000依0.477   89.000依0.045 101.000依0.019   70.000依0.034 
T. apicalis CMEH   23.000依0.057d 114.000依0.199   45.000依0.019   63.000依0.029   28.000依0.009 
CHEH   23.000依0.033e   78.000依0.275   93.000依0.086 117.000依0.003   82.000依0.021 
CEEH              119.000依0.022   98.000依0.417   83.000依0.032 118.000依0.023   91.000依0.015 
T. fuscobalteata CMEH   16.000依0.041f   80.000依0.114   40.000依0.111   69.000依0.038   63.000依0.020 
CHEH   18.000依0.041g   74.000依0.208   89.000依0.071 117.000依0.044   88.000依0.065 
CEEH              141.000依0.023 115.000依0.298   71.000依0.107   98.000依0.010   79.000依0.021 
T. fuscibasis CMEH   14.000依0.025h 104.000依0.116   55.000依0.035   82.000依0.021 102.000依0.028 
CHEH   20.000依0.054i 124.000依0.134 110.000依0.031 126.000依0.067   83.000依0.040 
CEEH 132.000依0.030   92.000依0.064   72.000依0.047   88.000依0.025   85.000依0.022 
Data are shown as the mean依SD, derived from three repeats. Means within a column followed by a different letter are significantly different. CMEP: crude MeOH 
extract of honey. CHEP: crude n-hexane extract of honey. CEEP: crude EtOAc extract of honey.
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three cell lines. Excluding the highest tested dose (10 µg/
mL), no significant cytotoxicity was observed with any of 
these four compounds against any of the cell lines except for 
BT-474, which, in contrast, showed a moderate to weak level 
of cytotoxic activity (50%-70% viable cell number) against 
four compounds at all tested doses (0.01-10.00 µg/mL).
4. Discussion
   There are many published studies suggesting that bee 
(mostly Apis sp., the honey bees) products exert a fairly 
diverse array of bioactivities, including anti-proliferation 
of cancer cell lines. However, so far very few studies have 
addressed the products of stingless bees, and none on the 
product of stingless bees native to Indonesia. In Thailand, 
antimicrobial and antiproliferative activities were reported 
from the crude extract and partial purified fractions of 
Tetragonula laeviceps propolis but the chemical structure 
of the active compounds has not been reported[22,23]. 
However, the major compounds in the geopropolis (propolis 
mixing with wax and soil in its constitution) of the stingless 
bee, Melipona scutellaris, in Brazil were identified as 
benzophenones, whilst, in contrast to honey bee propolis, 
flavonoids were absent. The geopropolis also had both 
antimicrobial and antiproliferative activities[24]. 
   In this study, five different human cancer derived cell 
lines were found to be differentially sensitive in terms of 
the cytotoxic activity to the crude extracts of different bee 
products and from different species. Overall, the HepG2 
cell line was sensitive to the CMEH and CEEH extracts from 
all four tested stingless bee species. The crude extracts of 
propolis from T. incisa and T. fuscobalteata were cytotoxic 
against most of the five cell lines, whilst the crude bee 
pollen extracts, and especially the CHEP extracts, were the 
least cytotoxic. 
   The bioactivities of bee products depend on the bee 
species, extraction method, harvesting period, geography, 
season, and so on[4,25,26]. For example, the preliminary 
phytochemical screening of A. mellifera propolis extracts 
from several areas in Java for antimicrobial activity against 
Mycobacterium tuberculosis and in vitro antiplasmodial 
activity against Plasmodium falciparum strains D6 and W2, 
revealed that the bioactivity depended upon the locality 
of harvesting the propolis[25]. Furthermore, the free radical 
scavenging and anti-Staphylococcus aureus activities 
of A. mellifera propolis from Indonesia varied with the 
propolis source, due to variations in the levels of four 
prenylflavanones according to the location of the plant resin 
sources, in this case Macaranga tanarius L. and Mangifera 
indica L.[26].
   This manuscript is the first study to report the 
antiproliferative effects of the crude extracts of Indonesian 
propolis from four species of stingless bees within the 
same region. Although they were only assayed as crude 
extracts, and only on transformed cell lines in vitro, with 
no comparison on untransformed cells, the observed 
cytotoxic activity is sufficient to merit their evaluation for 
application as crude extracts in addition to their enrichment 
and identification of the bioactive component(s) and their 
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Figure 1. The sensitivities of different cell lines to each of the six tested pure compounds.
Relative viable cell number of the (A) HepG2, (B) SW620, (C) ChaGo-I, (D) KATO-III and (E) BT474 cell lines after a 48 h treatment with the indicated pure 
compounds and concentrations. The data are shown as the mean依SD percentage of viable cell numbers relative to that of the control, as determined by the 
surrogate MTT assay, and are derived from three replications. 
Paula M. Kustiawan et al./Asian Pac J Trop Biomed 2014; 4(7): 549-556 555
potential application. For example, it has been previously 
reported that mixtures containing 25% (v/v) of a 90% minimum 
inhibition concentration of the ethanol extract of A. mellifera 
propolis with essential oils from aromatic plants, such as 
Caryophyllus aromaticus, Zingiber officinale, Cinnamomum 
zeylanicum and Mentha piperita, acted synergistically 
to inhibit the growth of Staphylococcus aureus[27]. This 
synergism was found in terms of the bacteristatic effects 
with all four essential oils, and for bactericidal effects 
with the Zingiber officinale and Cinnamomum zeylanicum 
oils. Although a diverse amount of research has supported 
that pure bioactive compounds in propolis offer the best 
bioactivity[16], the opposite trend that crude or unpurified 
extracts were more active, presumably due to synergism of 
compounds, has also been reported[28]. 
   Regardless, the crude extracts of the different bee 
products from these four Indonesian stingless bee species 
showed quiet marked variations in their in vitro cytotoxic 
activities across the five different human cancer derived 
cell lines. Accordingly, these cell lines were tested in a 
similar manner for their sensitivity to four known major 
bioactive (including cytotoxic activity) compounds in A. 
mellifera propolis as pure compounds (apigenin, CAPE, 
kaempferol and naringenin), in comparison to two currently 
used chemotherapeutic drugs (doxorubicin and 5-FU) as 
reference controls. The results revealed that kaempferol was 
cytotoxic to the ChaGo-I and KATO-III cell lines, apigenin 
was cytotoxic to KATO-III, and both naringenin and CAPE 
were cytotoxic to BT474. Although their cytotoxic activity 
was rather low compared to that of doxorubicin and 5-FU, 
there is still the possibility of improving them by chemical 
modification. In the future, the potential synergistic effects 
between pure compounds from bee products should be 
evaluated including their in vivo activities and potential for 
nanoencapsulation of the more hydrophobic compounds. 
For example, a polymeric nanoparticle-encapsulated 
formulation of A. mellifera propolis (propolis nanofood), 
utilizing micellar aggregates of cross-linked and random 
copolymers of N-isopropylacrylamide with N-vinyl-
2-pyrrolidone and poly (ethylene glycol) monoacrylate, 
has been used to overcome the poor aqueous solubility 
and minimal systemic bioavailability of the propolis 
nanofood[29]. The encapsulated propolis demonstrated a 
comparable in vitro therapeutic efficacy to that of the free 
propolis against a panel of human pancreatic cancer cell 
lines.
   One final aspect of concern is the dose of the sample, 
either in the crude or pure form. The results of this research 
showed that a specific in vitro concentration is required 
for the cytotoxic activity, otherwise, it may promote the 
proliferation of cancer cells via hormesis[30]. Consequently, 
further studies are necessary to confirm the bioactivity in 
vivo, and on normal cells, of these bee products as crude 
extracts and isolated pure compounds. 
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Comments 
Background
   Propolis has played an important role in foods, beverages, 
supplements and cosmetics for both medicinal treatment 
and beneficial health reasons (preventative medicine). It 
is used to prevent or reduce some diseases or symptoms. 
Propolis has been shown to have various biological activities, 
such as antibacterial, anti-inflammatory, antioxidant and 
anticancer properties, in support of its ancient use as a folk 
medicine in many regions of the world.
 
Research frontiers
   Stingless bee products have been used for sweetening 
and medicines from old times especially in the tropical 
regions. This research is dealing with the relationship 
between cytotoxic activity against human cancer cell lines, 
and stingless bee products (propolis, bee pollen and honey), 
in a new way using five stingless bee species native to 
Indonesia.
Related reports
   Although there have been very few reports on stingless 
bees products, it is known empirically that these products 
would have similar dietetic qualities as the ones from 
honeybees. However, some reports say that stingless bee’s 
honey have a little stronger anti-biotic functions than 
honeybee’s honey, which is due to the structure of the nest. 
Stingless bee’s honey is stocked in the honey-pots which 
are made of propolis, while honeybee’s honey-pots are 
made of beewax alone. This research also shows a brief 
account of the function; stingless bee’s honey should have a 
little high cytotoxic activities.
Innovations and breakthroughs
   One of the most noticeable honeybee products is propolis 
which has been well known to have various effective 
bioactivities. In the present study, authors have indicated 
enlighteningly that stingless bee’s propolis also should have 
the anti-cancer activities as well.
 
Applications
   This valuable research shows that some of the stingless 
bee products such as propolis and honey have notable 
anticancer activity for men, and should encourage fairly 
further actual applications.
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Peer review
   This is a valuable study work in which the authors threw 
light on the relationship between stingless bee products 
and human’s most serious diseases, which is cancer using 
human cancer cell lines in a new way, and showed that the 
propolis and honey from some species of stingless bees 
should have anticancer activities.
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